- Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: Workshop perspectives. Human pathology. 2004 Conference Paper GET IT
- High-resolution serum proteomic features for ovarian cancer detection. Endocrine-Related Cancer. 2004 Report GET IT
- General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer. Gynecologic Oncology. 2003 Information Resource GET IT
- Use of proteomic patterns in serum to identify ovarian cancer. The Lancet. 2002 Academic Article GET IT
Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 37